Chief executive John-Arne Røttingen also says the health science funder will back more “high risk, high reward” work
John-Arne Røttingen, chief executive of the Wellcome Trust. Photo credits: Wellcome Trust
The chief executive of the Wellcome Trust, which spends £1.6 billion a year on health research, has said it will adapt its strategy over the longer term to compensate for deep cuts in international science by the US.
John-Arne Røttingen said the trust could not fill all the immediate gaps left by the US withdrawal from health research, but it would explore adapting the trust’s spending to better support global health projects abandoned by Washington.
“We are looking into what are the longer-term impacts on the research system,” he told Science|Business. “How can we adapt our strategy?”
The new administration of Donald Trump has pulled much of its longstanding support for research in the developing world. In May, the country’s National Institutes of Health (NIH) https://sciencebusiness.net/news/international-news/european-research-p……
Discover the latest in research funding every Tuesday with Funding Newswire. Dive into detailed articles with our monthly or yearly subscriptions or start with a free trial
NOTE: if you're a part of one of our Network member organisations, you get free access by signing up with your institutional email. Verify your eligibility here.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.